ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness and Toxicity of Gemcitabine/Lobaplatin Versus Gemcitabine/Cisplatin as Second-line Treatment in Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01483300
Recruitment Status : Unknown
Verified January 2012 by Qingyuan Zhang, Harbin Medical University.
Recruitment status was:  Recruiting
First Posted : December 1, 2011
Last Update Posted : January 24, 2012
Sponsor:
Information provided by (Responsible Party):
Qingyuan Zhang, Harbin Medical University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : August 2014
  Estimated Study Completion Date : November 2014